John Libbey Eurotext

European Journal of Dermatology


Efficiency of topical imiquimod 5% cream in the management of chronic radiation dermatitis with multiple neoplasias Volume 16, issue 1, January-February 2006


See all figures

Department of Dermatology, (Skin Cancer Centre Charité), Charité University Hospital, Schumannstr. 20/21, 10117 Berlin, Germany, Department of Dermatology, Hospital Bremen-Mitte, Sankt-Jürgen-Straße 1, 28205 Bremen, Germany

The immune response modifier imiquimod 5% cream (Aldara ®) was locally applied to an extensive thoracic chronic radiation dermatitis for 2 weeks on a once daily basis. After moderate to severe irritative reactions with erythema and crusted erosions, areas cleared up within 4 weeks. The patient has now been in complete remission for 2 years